Cargando…

Two-compartment tumor metabolism: Autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells

Previously, we proposed a new paradigm to explain the compartment-specific role of autophagy in tumor metabolism. In this model, autophagy and mitochondrial dysfunction in the tumor stroma promotes cellular catabolism, which results in the production of recycled nutrients. These chemical building bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salem, Ahmed F., Whitaker-Menezes, Diana, Lin, Zhao, Martinez-Outschoorn, Ubaldo E., Tanowitz, Herbert B., Al-Zoubi, Mazhar Salim, Howell, Anthony, Pestell, Richard G., Sotgia, Federica, Lisanti, Michael P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404881/ https://www.ncbi.nlm.nih.gov/pubmed/22722266 http://dx.doi.org/10.4161/cc.20920

Ejemplares similares

Metabolic remodeling of the tumor microenvironment: Migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth
por: Carito, Valentina, et al.
Publicado: (2012)

CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth
por: Capparelli, Claudia, et al.
Publicado: (2012)

Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment
por: Sotgia, Federica, et al.
Publicado: (2011)

Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells
por: Fiorillo, Marco, et al.
Publicado: (2016)

Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production
por: Capparelli, Claudia, et al.
Publicado: (2012)

Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
por: Lamb, Rebecca, et al.
Publicado: (2015)

CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, “fueling” tumor growth via paracrine interactions, without an increase in neo-angiogenesis
por: Capparelli, Claudia, et al.
Publicado: (2012)

Cancer stem cell metabolism
por: Peiris-Pagès, Maria, et al.
Publicado: (2016)

Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4
por: Martinez-Outschoorn, Ubaldo E, et al.
Publicado: (2013)

Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells
por: Lamb, Rebecca, et al.
Publicado: (2015)

Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
por: Curry, Joseph M., et al.
Publicado: (2013)

Mitochondrial Fission Induces Glycolytic Reprogramming in Cancer-Associated Myofibroblasts, Driving Stromal Lactate Production, and Early Tumor Growth
por: Guido, Carmela, et al.
Publicado: (2012)

Cancer Metabolism: New Validated Targets for Drug Discovery
por: Sotgia, Federica, et al.
Publicado: (2013)

Genetic Induction of the Warburg Effect Inhibits Tumor Growth
por: Sotgia, Federica, et al.
Publicado: (2012)

Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling"
por: Pavlides, Stephanos, et al.
Publicado: (2010)

Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention?
por: Sotgia, Federica, et al.
Publicado: (2011)

Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)
por: Fiorillo, Marco, et al.
Publicado: (2016)

Targeting tumor-initiating cells: Eliminating anabolic cancer stem cells with inhibitors of protein synthesis or by mimicking caloric restriction
por: Lamb, Rebecca, et al.
Publicado: (2015)

The reverse warburg effect in osteosarcoma
por: Sotgia, Federica, et al.
Publicado: (2014)

Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity
por: Bonuccelli, Gloria, et al.
Publicado: (2016)

“Energetic” Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy
por: Fiorillo, Marco, et al.
Publicado: (2019)

Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy
por: De Francesco, Ernestina Marianna, et al.
Publicado: (2017)

The role of autophagy in regulating metabolism in the tumor microenvironment
por: Zhang, Panpan, et al.
Publicado: (2021)

Lack of Retinoblastoma Protein Shifts Tumor Metabolism from Glycolysis to OXPHOS and Allows the Use of Alternate Fuels
por: Suresh Babu, Vishnu, et al.
Publicado: (2022)

Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction
por: Adant, Isabelle, et al.
Publicado: (2022)

Editorial: Hallmark of cancer: Reprogramming of cellular metabolism
por: Kaur, Baljinder, et al.
Publicado: (2023)

Tumor Microenvironment and Metabolism
por: Yang, Li V.
Publicado: (2017)

Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide
por: Quann, Kevin, et al.
Publicado: (2013)

MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting Mitochondria and Eradicating Cancer Stem Cells (CSCs), With Anti-Tumor and Anti-Metastatic Activity In Vivo
por: Sargiacomo, Camillo, et al.
Publicado: (2021)

Metabolic reprogramming in tumors: Contributions of the tumor microenvironment
por: Lane, Andrew N., et al.
Publicado: (2019)

Mitochondrial biomarkers predict tumor progression and poor overall survival in gastric cancers: Companion diagnostics for personalized medicine
por: Sotgia, Federica, et al.
Publicado: (2017)

Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy
por: Lamb, Rebecca, et al.
Publicado: (2015)

Impact of Metabolism on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment
por: Kouidhi, Soumaya, et al.
Publicado: (2017)

Cancer stem cells (CSCs): metabolic strategies for their identification and eradication
por: De Francesco, Ernestina M., et al.
Publicado: (2018)

NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting “stemness”
por: Bonuccelli, Gloria, et al.
Publicado: (2017)

Mitochondrial mRNA transcripts predict overall survival, tumor recurrence and progression in serous ovarian cancer: Companion diagnostics for cancer therapy
por: Sotgia, Federica, et al.
Publicado: (2017)

Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment
por: Leroi, Natacha, et al.
Publicado: (2016)

GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment
por: De Francesco, Ernestina M., et al.
Publicado: (2017)

Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
por: Renner, Kathrin, et al.
Publicado: (2017)

Metabolic pattern formation in the tumor microenvironment
por: Dai, Ziwei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_df0t5boel8he5svs936o4ftg9j